AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD
NCT05683379 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-11-25
Summary
This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).
Conditions
Interventions
- DIAGNOSTIC_TEST
-
AAV8 DetectCDx
An in vitro diagnostic assay to detect antibodies to AAV8 in human serum specimens.
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 0 Years
- Max Age
- 25 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-20
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
NCT05996003 ·Status: RECRUITING ·Phase: PHASE2
-
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
NCT05693142 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Multicenter Observational Study of Myotonic Dystrophy Type 1
NCT02308657 ·Status: COMPLETED
-
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping
NCT01539772 ·Status: UNKNOWN
-
Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study
NCT02780492 ·Status: COMPLETED
-
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
NCT02420379 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
NCT02972580 ·Status: ACTIVE_NOT_RECRUITING
-
Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
NCT05016908 ·Status: RECRUITING
-
A Diagnostic Test for Dementia With Lewy Bodies
NCT05479552 ·Status: ACTIVE_NOT_RECRUITING
-
Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)
NCT03319030 ·Status: COMPLETED
-
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
NCT01484678 ·Status: RECRUITING
-
Research of Biomarkers in Duchenne Muscular Dystrophy Patients
NCT01380964 ·Status: COMPLETED
-
Natural History of Duchenne Muscular Dystrophy
NCT03882827 ·Status: RECRUITING
-
A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
NCT04475926 ·Status: ACTIVE_NOT_RECRUITING
-
Study Evaluating MYO-029 in Adult Muscular Dystrophy
NCT00104078 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Extracellular RNA Biomarkers of Myotonic Dystrophy
NCT05020002 ·Status: RECRUITING
-
Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations
NCT05833633 ·Status: UNKNOWN
-
Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)
NCT03867435 ·Status: TERMINATED
-
Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
NCT00159250 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies
NCT02109692 ·Status: UNKNOWN ·Phase: NA
-
Molecular Analysis of Patients With Neuromuscular Disease
NCT00390104 ·Status: RECRUITING
-
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
NCT01540409 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Eteplirsen in DMD Patients
NCT02255552 ·Status: COMPLETED ·Phase: PHASE3
-
Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD
NCT02834650 ·Status: COMPLETED ·Phase: NA
-
Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy
NCT00312247 ·Status: COMPLETED